Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Literature DB >> 3262459

Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

H Repo¹, M Jäättelä, M Leirisalo-Repo, M Hurme.

Abstract

We studied production of tumour necrosis factor (TNF) and interleukin 1 (IL-1) by using purified peripheral blood monocytes of patients with previous yersinia arthritis (YA) and of healthy HLA-B27 positive and negative controls. Lipopolysaccharide-exposed cells of HLA-B27 positive and negative patients, and those of HLA-B27 positive controls, generated significantly more TNF than did HLA-B27 negative control cells. There was a positive correlation between the levels of TNF and IL-1. Our results give credence to the view that augmented production of phlogistic mediators may contribute to inflammatory symptoms in patients with HLA-B27 associated disease.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1988 PMID： 3262459 PMCID： PMC1541576

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

31 in total

1. Lack of correlation between HLA-B27 like antigenic epitopes on Shigella flexneri and the occurrence of reactive arthritis.

Authors: C G van Bohemen; A J Nabbe; F C Grumet; J E Landheer; H J Dinant; H C Zanen
Journal: Clin Exp Immunol Date: 1986-09 Impact factor: 4.330

2. Molecular mimicry and autoimmune disease.

Authors: M B Oldstone
Journal: Cell Date: 1987-09-11 Impact factor: 41.582

Review 3. Yersinia arthritis. Acute clinical picture and long-term prognosis.

Authors: M Leirisalo-Repo
Journal: Contrib Microbiol Immunol Date: 1987

4. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

Authors: M R Shalaby; M A Palladino; S E Hirabayashi; T E Eessalu; G D Lewis; H M Shepard; B B Aggarwal
Journal: J Leukoc Biol Date: 1987-03 Impact factor: 4.962

5. Stimulation of neutrophils by tumor necrosis factor.

Authors: S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal: J Immunol Date: 1986-06-01 Impact factor: 5.422

6. Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.

Authors: N Feltelius; R Hällgren; P Venge
Journal: Ann Rheum Dis Date: 1987-05 Impact factor: 19.103

7. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors: W J Ming; L Bersani; A Mantovani
Journal: J Immunol Date: 1987-03-01 Impact factor: 5.422

8. Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400).

Authors: R Serrander; K E Magnusson; E Kihlström; T Sundqvist
Journal: Scand J Infect Dis Date: 1986

9. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors: C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal: J Exp Med Date: 1986-06-01 Impact factor: 14.307

10. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease.

Authors: P L Schwimmbeck; D T Yu; M B Oldstone
Journal: J Exp Med Date: 1987-07-01 Impact factor: 14.307

16 in total

1. Peripheral blood monocytes from patients with reactive arthritis show normal production of tumour necrosis factor-alpha.

Authors: H Repo; A Lauhio; M Jäättelä; P Saikku; M Leirisalo-Repo
Journal: Clin Exp Immunol Date: 1991-03 Impact factor: 4.330

2. Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.

Authors: M Leirisalo-Repo; A Lauhio; H Repo
Journal: Ann Rheum Dis Date: 1990-08 Impact factor: 19.103

Review 3. Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors: R Tertti; P Toivanen
Journal: Ann Rheum Dis Date: 1991-10 Impact factor: 19.103

Review 4. HLA-B27 and bacteria.

Authors: J Uksila; P Toivanen
Journal: Clin Rheumatol Date: 1996-01 Impact factor: 2.980

5. The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro.

Authors: F Martinez; J W Coleman
Journal: Clin Exp Immunol Date: 1989-05 Impact factor: 4.330